TY - JOUR
T1 - Anxiety, depression, and fear after coronavirus disease 2019 infection and their association with long coronavirus disease symptoms
AU - Saito, Ayaka
AU - Otake, Shiro
AU - Ohgino, Keiko
AU - Bun, Shogyoku
AU - Mimura, Yu
AU - Ito, Daisuke
AU - Miyazaki, Naoki
AU - Nagashima, Kengo
AU - Terai, Hideki
AU - Chubachi, Shotaro
AU - Masaki, Katsunori
AU - Miyata, Jun
AU - Kawada, Ichiro
AU - Namkoong, Ho
AU - Hashiguchi, Mizuha
AU - Kagyo, Junko
AU - Shiomi, Tetsuya
AU - Masuzawa, Keita
AU - Asakura, Takanori
AU - Nakayama, Sohei
AU - Suzuki, Yusuke
AU - Minematsu, Naoto
AU - Manabe, Tadashi
AU - Fukui, Takahiro
AU - Funatsu, Yohei
AU - Koh, Hidefumi
AU - Fukunaga, Koichi
N1 - Publisher Copyright:
Copyright © 2025 Saito, Otake, Ohgino, Bun, Mimura, Ito, Miyazaki, Nagashima, Terai, Chubachi, Masaki, Miyata, Kawada, Namkoong, Hashiguchi, Kagyo, Shiomi, Masuzawa, Asakura, Nakayama, Suzuki, Minematsu, Manabe, Fukui, Funatsu, Koh and Fukunaga.
PY - 2025
Y1 - 2025
N2 - Introduction: The coronavirus disease 2019 (COVID-19) pandemic has had widespread physical and psychological repercussions. Additionally, long COVID symptoms such as fatigue, dyspnea, and cognitive impairment have been well-documented; however, their associations with mental health symptoms remain unclear. This study investigated the relationships between long COVID and symptoms of anxiety, depression, and COVID-19-related fear using validated psychological assessment tools. Methods: This nationwide, prospective cohort study enrolled 1,066 individuals who recovered from COVID-19. The participants completed self-report questionnaires at 3, 6, and 12 months after diagnosis. Long COVID symptoms and psychological status were assessed using the Hospital Anxiety and Depression Scale (HADS) and Fear of COVID-19 Scale (FCV-19S). Statistical analyses were used to examine associations between long COVID symptoms and psychological scores while accounting for clinicodemographic factors. Results: Three months after diagnosis, 20.1% of the participants exhibited high anxiety (HADS-Anxiety [A] score ≥ 8), 23.6% had high depression (HADS-Depression [D] score ≥ 8), and 35.3% reported high levels of COVID-19-related fear (FCV-19S score ≥ 21). High HADS-A and HADS-D scores were significantly associated with younger age, female sex, and mild initial illness severity. Individuals with high HADS scores reported significantly greater long COVID symptoms; headaches and fatigue were associated with high anxiety scores and impaired concentration was associated with high depression scores. Conclusions: This study highlighted the significant associations between mental health symptoms and long COVID, emphasizing the need for integrated psychological support in post-COVID care. Addressing anxiety, depression, and fear-related concerns may contribute to improved management of long COVID symptoms and enhance overall patient well-being.
AB - Introduction: The coronavirus disease 2019 (COVID-19) pandemic has had widespread physical and psychological repercussions. Additionally, long COVID symptoms such as fatigue, dyspnea, and cognitive impairment have been well-documented; however, their associations with mental health symptoms remain unclear. This study investigated the relationships between long COVID and symptoms of anxiety, depression, and COVID-19-related fear using validated psychological assessment tools. Methods: This nationwide, prospective cohort study enrolled 1,066 individuals who recovered from COVID-19. The participants completed self-report questionnaires at 3, 6, and 12 months after diagnosis. Long COVID symptoms and psychological status were assessed using the Hospital Anxiety and Depression Scale (HADS) and Fear of COVID-19 Scale (FCV-19S). Statistical analyses were used to examine associations between long COVID symptoms and psychological scores while accounting for clinicodemographic factors. Results: Three months after diagnosis, 20.1% of the participants exhibited high anxiety (HADS-Anxiety [A] score ≥ 8), 23.6% had high depression (HADS-Depression [D] score ≥ 8), and 35.3% reported high levels of COVID-19-related fear (FCV-19S score ≥ 21). High HADS-A and HADS-D scores were significantly associated with younger age, female sex, and mild initial illness severity. Individuals with high HADS scores reported significantly greater long COVID symptoms; headaches and fatigue were associated with high anxiety scores and impaired concentration was associated with high depression scores. Conclusions: This study highlighted the significant associations between mental health symptoms and long COVID, emphasizing the need for integrated psychological support in post-COVID care. Addressing anxiety, depression, and fear-related concerns may contribute to improved management of long COVID symptoms and enhance overall patient well-being.
KW - anxiety
KW - depression
KW - fear
KW - long COVID
KW - mental health
KW - symptoms
UR - https://www.scopus.com/pages/publications/105016799019
UR - https://www.scopus.com/pages/publications/105016799019#tab=citedBy
U2 - 10.3389/fpsyt.2025.1672447
DO - 10.3389/fpsyt.2025.1672447
M3 - Article
AN - SCOPUS:105016799019
SN - 1664-0640
VL - 16
JO - Frontiers in Psychiatry
JF - Frontiers in Psychiatry
M1 - 1672447
ER -